Cargando…

Dynamic Effects of the Third Generation Bisphosphonate of Risedronate on Rat Osteoporotic Fractures for Clinical Usage Guidance

OBJECTIVE: To better understand the risks of bisphosphonates in order to develop guidance for appropriate clinical usage, to compared femoral fracture healing at different time points and to explore the effects of Residronate on fracture healing. METHODS: Osteoporosis model was achieved by ovariecto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ke, Cheng‐hui, Li, Hong‐yun, Yang, Dan, Ying, Hao, Xu, Jun, Wang, Jian, Zhu, Hong‐wen, Wang, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2021
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654647/ https://www.ncbi.nlm.nih.gov/pubmed/34676672 http://dx.doi.org/10.1111/os.13158

Ejemplares similares

Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: The risedronate and alendronate (REAL) cohort study
por: Silverman, S. L., et al.
Publicado: (2006)

Efficacy of teriparatide compared with risedronate on FRAX(®)-defined major osteoporotic fractures: results of the VERO clinical trial
por: Body, J.-J., et al.
Publicado: (2020)

The Efficacy of Bisphosphonates for Prevention of Osteoporotic Fracture: An Update Meta-analysis
por: Byun, Ji-Hye, et al.
Publicado: (2017)

First Indian prospective randomized comparative study evaluating adherence and compliance of postmenopausal osteoporotic patients for daily alendronate, weekly risedronate and monthly ibandronate regimens of bisphosphonates
por: Tandon, Vishal R., et al.
Publicado: (2014)

Radiological Factors Associated with Bisphosphonate Treatment Failure and Their Impact on Fracture Healing in Postmenopausal Women with Osteoporotic Vertebral Fractures
por: Kim, Hong Jin, et al.
Publicado: (2023)

Influence of Early Bisphosphonate Administration for Fracture Healing in Patients with Osteoporotic Proximal Humerus Fractures
por: Seo, Joong-Bae, et al.
Publicado: (2016)

Effect of Sequential Treatment with Bisphosphonates After Teriparatide in Ovariectomized Rats: A Direct Comparison Between Risedronate and Alendronate
por: Yano, Tetsuo, et al.
Publicado: (2017)

Bisphosphonates for Secondary Prevention of Osteoporotic Fractures: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
por: Shi, Lei, et al.
Publicado: (2019)

Bisphosphonate related osteonecrosis of the jaws (BRONJ) in osteoporotic males
por: Kwon, Yong-Dae, et al.
Publicado: (2016)

Fluorescent Risedronate Analogues Reveal Bisphosphonate Uptake by Bone Marrow Monocytes and Localization Around Osteocytes In Vivo
por: Roelofs, Anke J, et al.
Publicado: (2010)

Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis
por: Thomasius, Friederike, et al.
Publicado: (2021)

BISPHOSPHONATE-INDUCED MAXILLOFACIAL OSTEONECROSIS IN OSTEOPOROTIC INDIVIDUALS
por: da Silva Santos, Paulo Sérgio, et al.
Publicado: (2015)

Effects of risedronate on fracture risk in postmenopausal women with osteopenia
por: Siris, E. S., et al.
Publicado: (2007)

Sustained anti-osteoporotic action of risedronate compared to anti-RANKL antibody following discontinuation in ovariectomized mice
por: Omiya, Toshinobu, et al.
Publicado: (2020)

Anti-fracture Efficacy of Monthly Risedronate Compared with That of Weekly Risedronate in Postmenopausal Korean Women with Osteoporosis: A Nationwide Cohort Study
por: Cho, Yong Ho, et al.
Publicado: (2020)

A Case Report of Bisphosphonate-induced Bilateral Osteoporotic Subtrochanteric Fracture Femurii: Review of Literature
por: Uppin, Rajendra, et al.
Publicado: (2016)

Does the Time of Postoperative Bisphosphonate Administration Affect the Bone Union in Osteoporotic Intertrochanteric Fracture of Femur?
por: Cho, Yoon Je, et al.
Publicado: (2015)

Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
por: Yeh, Wen-Ling, et al.
Publicado: (2017)

Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: A meta-analysis
por: Peng, Jing, et al.
Publicado: (2016)

Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA
por: Eisman, John A., et al.
Publicado: (2023)

Comparison of Monthly Ibandronate Versus Weekly Risedronate in Preference, Convenience, and Bone Turnover Markers in Korean Postmenopausal Osteoporotic Women
por: Chung, Yoon-Sok, et al.
Publicado: (2009)

Risedronate’s Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis
por: Gates, Brian J., et al.
Publicado: (2012)

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
por: Masud, Tahir, et al.
Publicado: (2009)

Effects of Risedronate on Osteoarthritis of the Knee
por: Iwamoto, Jun, et al.
Publicado: (2010)

Adherence of bisphosphonate and decreased risk of clinical vertebral fracture in osteoporotic patients: A propensity score matching analysis
por: Kim, Seihee, et al.
Publicado: (2022)

Changes in Serum Osteocalcin are Not Associated with Changes in Glucose or Insulin for Osteoporotic Patients Treated with Bisphosphonate
por: Hong, Seong-hun, et al.
Publicado: (2013)

Beneficial effect of risedronate for preventing recurrent hip fracture in the elderly Japanese women
por: Osaki, M., et al.
Publicado: (2011)

Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype
por: Tummolo, Albina, et al.
Publicado: (2013)

Immunomodulatory Effect of Bisphosphonate Risedronate Sodium on CD163(+) Arginase 1(+) M2 Macrophages: The Development of a Possible Supportive Therapy for Angiosarcoma
por: Fujimura, Taku, et al.
Publicado: (2013)

Risk Factors of New Adjacent Compression Fracture after Percutaneous Vertebroplasty: Effectiveness of Bisphosphonate in Osteoporotic or Osteopenic Elderly Patients
por: Seo, Dae-Hyun, et al.
Publicado: (2014)

Combination of a third generation bisphosphonate and replication-competent adenoviruses augments the cytotoxicity on mesothelioma
por: Jiang, Yuanyuan, et al.
Publicado: (2016)

The effect of type 2 diabetes mellitus on the prognosis of osteoporotic vertebral compression fracture with osteoporotic fracture classification after vertebroplasty
por: Wang, Zixiang, et al.
Publicado: (2023)

Effects of ergosteroside combined risedronate on fracture healing and BMP-2, BMP-7 and VEGF expression in rats
por: Xu, Xiaofeng, et al.
Publicado: (2021)

Osteoporotic fractures in second-generation immigrants and Swedish natives
por: Wändell, P., et al.
Publicado: (2021)

Once-monthly risedronate for postmenopausal osteoporosis
por: Casadei, Kristina, et al.
Publicado: (2010)

Use of risedronate for consolidation and callus formation in Colles fractures in postmenopausal women: SOLID study
por: Oliveira, Lindomar Guimarães, et al.
Publicado: (2015)

Bone turnover is adequately suppressed in osteoporotic patients treated with bisphosphonates in daily practice
por: Eekman, Danielle A, et al.
Publicado: (2011)

Eldecalcitol improves chair-rising time in postmenopausal osteoporotic women treated with bisphosphonates
por: Iwamoto, Jun, et al.
Publicado: (2014)

The effects of bisphosphonates on osteoporotic patients after lumbar fusion: a meta-analysis
por: Liu, Wen-bin, et al.
Publicado: (2018)

Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low- and high energy fracture conditions
por: Zimmermann, Elizabeth A., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_npg87ip0ckchre523g8bpprp2b